Barlow Wealth Partners’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.44M Buy
24,463
+433
+2% +$101K 0.7% 32
2026
Q1
$5.63M Sell
24,030
-107
-0.4% -$24.9K 0.63% 33
2025
Q4
$4.93M Sell
24,137
-675
-3% -$133K 0.53% 35
2025
Q3
$4.79M Sell
24,812
-787
-3% -$135K 0.53% 34
2025
Q2
$3.98M Sell
25,599
-135
-0.5% -$20.8K 0.48% 37
2025
Q1
$3.98M Sell
25,734
-82
-0.3% -$12.8K 0.52% 39
2024
Q4
$3.74M Sell
25,816
-2,553
-9% -$396K 0.47% 39
2024
Q3
$4.53M Sell
28,369
-39,015
-58% -$6.22M 0.59% 40
2024
Q2
$10.5M Sell
67,384
-29,399
-30% -$4.37M 1.46% 30
2024
Q1
$14.3M Buy
96,783
+1,531
+2% +$244K 1.94% 19
2023
Q4
$14.9M Buy
+95,252
New +$14.6M 2.12% 19

Other funds holding JNJ

Barlow Wealth Partners's JNJ Position: Q2 2026 in Review

Barlow Wealth Partners increased its Johnson & Johnson (JNJ) stake by 1.8% in Q2 2026, buying an estimated $101K and bringing the position to 24,463 shares worth $6.44M. The position accounts for 0.7% of the portfolio, ranked #32.

Barlow Wealth Partners first reported a position in JNJ in Q4 2023 and has held it in 11 quarters since. The position peaked at $14.9M in Q4 2023. 2,379 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Barlow Wealth Partners held 24,463 shares of Johnson & Johnson worth $6.44M as of Q2 2026.
  • Barlow Wealth Partners bought 433 Johnson & Johnson shares in Q2 2026, an estimated $101K.
  • Johnson & Johnson made up 0.7% of Barlow Wealth Partners's portfolio in Q2 2026, its #32 holding.
  • Barlow Wealth Partners first reported a position in Johnson & Johnson in Q4 2023 and has held it in 11 quarters since.
  • Barlow Wealth Partners's Johnson & Johnson position peaked at $14.9M in Q4 2023.
  • 2,379 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Barlow Wealth Partners's 13F filing for Q2 2026, filed 14 Jul 2026.